For the quarter ending 2025-12-31, PPCB has $15,111,532 in assets. $3,659,267 in debts.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash | 561,237 | 602,737 | 12,088 | |
| Gst tax receivable | 16,994 | 8,383 | 5,302 | |
| Prepaid expenses - current portion | 7,127,293 | 8,143,532 | 8,334,046 | |
| Other current assets | 1,400 | 8,828 | 1,380 | |
| Total current assets | 7,706,924 | 8,763,480 | 8,352,816 | |
| Deferred offering costs | - | 15,000 | 291,773 | |
| Prepaid expenses - long-term portion | 7,347,310 | 9,136,572 | 10,925,835 | |
| Security deposit - related party | 2,000 | 1,986 | 1,971 | |
| Operating lease right-of-use assets, net - related party | 50,901 | 56,279 | 59,413 | |
| Property and equipment, net | 4,397 | 2,364 | - | |
| Total assets | 15,111,532 | 17,975,681 | 19,631,808 | |
| Due to former director - related party-Former Director | - | - | 0 | |
| Loan payable-Former Director | - | - | 0 | |
| Notes payable, net of discount | 0 | - | 543,312 | |
| Accounts payable | 957,483 | 1,072,108 | 1,249,596 | |
| Accrued expenses and other payables | 860,463 | 842,154 | 1,486,550 | |
| Accrued interest | 168,152 | 150,443 | 190,795 | |
| Loans payable-Nonrelated Party | 65,280 | 65,280 | 65,280 | |
| Convertible notes, net of discounts and including put premiums | 55,000 | 106,968 | 537,921 | |
| Operating lease liability - related party, current portion | 21,604 | 20,500 | - | |
| Warrant liability | 288,635 | - | - | |
| Operating lease liability - related party, current portion-Related Party | 21,604 | 20,500 | 17,664 | |
| Embedded conversion option liabilities | - | 167,878 | 403,892 | |
| Loans payable-Related Party | 472,083 | 460,240 | 415,329 | |
| Employee benefit liability | 703,190 | 686,863 | 667,901 | |
| Embedded conversion option liabilities | 32,128 | - | - | |
| Total current liabilities | 3,624,018 | 3,572,434 | 5,578,240 | |
| Loan payable - long-term - related party, net of discount | 0 | 0 | 105,627 | |
| Operating Lease Liability Noncurrent | 35,249 | 42,080 | - | |
| Operating lease liability - long-term portion - related party | 35,249 | 42,080 | 41,749 | |
| Loan payable - long-term - related party, net of discount | 0 | 0 | - | |
| Total non-current liabilities | 35,249 | 42,080 | 147,376 | |
| Total liabilities | 3,659,267 | 3,614,514 | 5,725,616 | |
| Temporary equity convertible preferred stock series c - 0.01 par value, 10,000 stated value, 9,900 shares designated and authorized, 100 (liquidation value of 1,000,000) and none issued and outstanding at december 31, 2025 and june 30, 2025, respectively | 1,000,000 | - | - | |
| Preferred stock, value-Series APreferred Stock | 0 | 0 | - | |
| Preferred stock, value-Series BPreferred Stock | 0 | 0 | 0 | |
| Common stock, 0.001 par value 10,000,000,000 shares authorized 13,449,688 and 11,611,782 shares issued and outstanding as of december 31, 2025 and june 30, 2025, respectively | 13,450 | 12,807 | 11,612 | |
| Common stock issuable (7,750 and 7,750 shares as of december 31, 2025 and june 30, 2025, respectively) | 8 | 519 | 8 | |
| Additional paid-in capital | 143,640,067 | 143,517,615 | 138,243,652 | |
| Accumulated deficit | -134,482,898 | -130,459,258 | -125,621,520 | |
| Treasury stock (0.001 share) | 46,477 | 46,477 | 46,477 | |
| Accumulated other comprehensive income | 1,328,115 | 1,335,961 | 1,318,917 | |
| Total stockholders equity | 10,452,265 | 14,361,167 | 13,906,192 | |
| Total liabilities and stockholders equity | 15,111,532 | 17,975,681 | 19,631,808 | |
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)